Clinical Trials Browser

Phase 4 × Lymphoma, Non-Hodgkin × ibritumomab tiuxetan × Clear all

NCT00168727 2023-08-23

Zevalin® Followed by Rituxan® Maintenance in Previously Treated Low Grade Non-Hodgkin's Lymphoma

Phase 4 Completed

Lymphoma, Non-Hodgkin